Suture Line Botulinum Toxin Administration for Headache Relief

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for treating headaches, particularly those involving botulinum toxins, often lack precision and effectiveness, as they involve general injections into superficial muscles and subcutaneous tissue without targeting specific pain sources, leading to incomplete relief and potential side effects.

Innovation Solution

Administering botulinum neurotoxin specifically along the suture lines of the skull, where nerve endings are accessible, to target and alleviate headache pain, using techniques such as subdermal injections or transdermal application, allowing for focused delivery and reduced dosages.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If botulinum toxin is administered generally into superficial muscles and subcutaneous tissue, then the treatment covers a broad area, but the precision and effectiveness in targeting specific pain sources is reduced

Engineering Contradiction:
Improveprecision of toxin administrationVSAvoiddosage of botulinum toxin
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent applies local quality by identifying and treating specific local areas (suture lines) rather than administering toxin broadly. The suture lines serve as precise anatomical landmarks where nerve endings are accessible, allowing the toxin to be concentrated exactly where needed to block pain signals, thereby improving precision while reducing the total quantity required.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent segments the treatment approach by dividing the skull into distinct suture line regions (coronal, sagittal, lambdoid, occipitomastoid sutures). Each suture line is treated as a separate target zone, allowing precise localization of pain sources and targeted administration of toxin to specific nerve pathways rather than blanket treatment of the entire head.

Inventive Principle:
Principle #1Segmentation

2Duration of action of moving object

If higher doses of botulinum toxin are administered, then the duration of relief is extended, but side effects increase

Engineering Contradiction:
Improveduration of headache reliefVSAvoidside effects of toxin administration
Core Design Contradiction:
Duration of action of moving objectVSObject-affected harmful factors

Solution Approach 1:

By concentrating the toxin at specific suture line locations where pain-generating nerves are accessible, the patent achieves effective pain blockade with lower total doses. This localized approach extends duration of relief by ensuring the toxin reaches its target efficiently, while minimizing side effects through reduced overall exposure and avoidance of non-target tissues.

Inventive Principle:
Principle #3Local quality

3Ease of operation

If general injection methods are used, then the treatment is easier to administer, but the effectiveness in alleviating specific headache pain is reduced

Engineering Contradiction:
Improveease of toxin administrationVSAvoideffectiveness of headache treatment
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The patent employs preliminary action by first identifying and marking the suture line locations on the patient's skull before administering the toxin. This preparatory step of locating the precise anatomical landmarks ensures that subsequent injections are accurately placed at the correct nerve pathways, maintaining ease of administration while significantly improving treatment effectiveness and reliability.

Inventive Principle:
Principle #10Preliminary action

Data Source

PatentUS10874722B2Suture line administration technique using botulinum toxins
Publication Date: 2020.12.29 ALLERGAN INC
  • US10874722B2 patent drawing
  • US10874722B2 patent drawing
  • US10874722B2 patent drawing

AI summary

The present invention utilizes patient-specific landmarks in order to treat headache pain. In one aspect, the present invention relates to the administration of Clostridial toxins, such as a botulinum neurotoxin, to a patient suffering from a headache pain, where the location of administration of the botulinum toxin is based upon at least one suture line of the patient's skull.